Plasmepsin
From Proteopedia
(Difference between revisions)
Line 7: | Line 7: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
+ | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
- | + | *Histo-Aspartic Protease | |
- | [[3fns]], [[3qvc]] – PfHAP - ''Plasmodium falciparum''<br /> | + | **[[3fns]], [[3qvc]] – PfHAP - ''Plasmodium falciparum''<br /> |
- | [[3fnt]] – PfHAP + pepstatin<br /> | + | **[[3fnt]] – PfHAP + pepstatin<br /> |
- | [[3fnu]], [[3qvi]] – PfHAP + inhibitor<br /> | + | **[[3fnu]], [[3qvi]] – PfHAP + inhibitor<br /> |
- | + | *Plasmepsin I | |
- | [[3qrv]] – PfPlm I residues 117-457<br /> | + | **[[3qrv]] – PfPlm I residues 117-457<br /> |
- | [[3qs1]] - PfPlm I residues 117-457 + inhibitor | + | **[[3qs1]] - PfPlm I residues 117-457 + inhibitor |
- | + | *Plasmepsin II | |
- | [[1lf4]] – PfPlm II<br /> | + | **[[1lf4]] – PfPlm II<br /> |
- | [[3f9q]] – PfPlm II (mutant)<br /> | + | **[[3f9q]] – PfPlm II (mutant)<br /> |
- | [[2r9b]] – PfPlm II + peptide inhibitor<br /> | + | **[[2r9b]] – PfPlm II + peptide inhibitor<br /> |
- | [[1w6h]], [[2bju]], [[1lf2]], [[1lf3]], [[1lee]], [[2igx]], [[2igy]] – PfPlm II + inhibitor<br /> | + | **[[1w6h]], [[2bju]], [[1lf2]], [[1lf3]], [[1lee]], [[2igx]], [[2igy]] – PfPlm II + inhibitor<br /> |
- | [[1w6i]], [[1xdh]], [[1xe5]], [[1xe6]], [[1me6]], [[1sme]] – PfPlm II + pepstatin derivative<br /> | + | **[[1w6i]], [[1xdh]], [[1xe5]], [[1xe6]], [[1me6]], [[1sme]] – PfPlm II + pepstatin derivative<br /> |
- | [[1m43]] - PfPlm II (mutant) + pepstatin derivative<br /> | + | **[[1m43]] - PfPlm II (mutant) + pepstatin derivative<br /> |
- | + | *Proplasmepsin II | |
- | [[1pfz]] - PfProPlm II<br /> | + | **[[1pfz]] - PfProPlm II<br /> |
- | [[1miq]] – PvProPlm II – ''Plasmodium vivax''<br /> | + | **[[1miq]] – PvProPlm II – ''Plasmodium vivax''<br /> |
- | [[1qs8]] - PvPlm + pepstatin derivative<br /> | + | **[[1qs8]] - PvPlm + pepstatin derivative<br /> |
- | + | *Plasmepsin IV | |
- | + | ||
- | + | ||
- | + | ||
+ | **[[2anl]] – Plm IV + statine derivative – ''Plasmodium malariae''<br /> | ||
+ | **[[1ls5]] - PfPlm IV + pepstatin derivative<br /> | ||
+ | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Revision as of 10:23, 3 December 2014
Template:STRUCTURE 3fns Plasmepsin (Plm) is a hemoglobin-degrading enzyme produced by the plasmodium parasite. It is a potential target for anti-malaria drugs. It is an aspartic acid protease having 2 aspartic acid residues in the active site. Ten Plm isoforms are known which are named Plm I, II, etc and Histo-Aspartic Protease (HAP). ProPml II exhibits a large shift between its domains which renders the protease inactive.
3D structures of plasmepsin
Updated on 03-December-2014
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Joel L. Sussman, Jaime Prilusky